Medical Forum / Diseases and Disorders / Prostate Cancer / July 2005
Number of prostate biopsies
|
|
Thread rating:  |
Ray K - 30 Jun 2005 21:42 GMT I originally posted the following question to sci.med.prostate.bph. One responder suggested I also post it here. Some of the replies are included.
I originally asked (6/29):
"If during an DRE the uro feels a nodule (firm, but not hard), is it really necessary to take more than one biopsy, right from the nodule? If there is cancer, it seems to me it would be centered in nodule, so 11 more jabs around the prostate seem unnecessary unless there is some kind of treatment that is highly localized."
Some additional info not in the original post: PSA 9.8 (the previous high was 9.1 in Sept 2002, with interim values of as low as 7.4 two months later following 2 weeks of Cipro, and a reading of 8.8 in April 2004); nodule about 0.5 cm, based on DRE.
Ed replied (6/29):
Once they have you there with the probe in place, let them take the samples they need. It is uncomfortable and stings a bit and is undignified and stressful, but really it doesn't last long and it is not that painful.
There could be cancer even if no nodule was felt. I don't think there is any restriction to where cancer might be (if there is cancer present).
Take advantage of this excellent medical tool. Let them find out what is up to perhaps set your mind at rest, or to decide what treatment you might need. Your life could be at stake...
Derek replied (6/29):
You can never have too many. Last time I had 16.
Ed Friedman replied (6/30):
The importance in taking multiple cores from around the prostate is in determining the percentage of cores which show up positive for prostate cancer. Basically, if 50% or more come up positive, then there is almost no chance that localized treatment will effect a cure.
I replied to Ed F as follows (6/30):
Thanks, Ed, this is the kind of answer I was looking for. The question then becomes, what exactly is localized treatment? Surgery, yes. Seeds, yes. Chemo through a catheter directly into the prostate, yes. Intravenous chemotherapy, no. Whole body radiation, no.
Another question is, just how finely localized can a treatment be? Suppose just the firm nodule tests positive, but none of the surrounding other 11 samples do. I wonder what the treatment would be.
Ray
Matthew Emme - 01 Jul 2005 01:16 GMT On 6/30/05 3:42 PM, in article 1PYwe.4261$SQ1.2000@fe09.lga, "Ray K" <raykosXXX@optonline.net> wrote:
> I originally posted the following question to sci.med.prostate.bph. One > responder suggested I also post it here. Some of the replies are included. [quoted text clipped - 6 lines] > more jabs around the prostate seem unnecessary unless there is some kind > of treatment that is highly localized." People did that for years with the digitally directed biopsy. They had a needle guide that went over the finger then they put the biopsy needle into this guide then the finger felt where the lump is and a core could be taken at the spot of this lump. The short answer is that the multiple biopsy approach using ultrasound seems to work better and this finger directed way of doing things has kind of fallen by the wayside.
> Ed replied (6/29): > [quoted text clipped - 10 lines] > is up to perhaps set your mind at rest, or to decide what treatment > you might need. Your life could be at stake... Many times that cancer does not seem to show up in the area you thought it would be.
> Derek replied (6/29): > > You can never have too many. Last time I had 16. I seem to do more often do in the 10-12 range. In people who have had multiple negative biopsies in the past I have been know to increase this number by a large amount (20+). To get more than about 15 cores out of people you tend to need a little IV meds to take the edge off of things or they just will not sit still.
> Ed Friedman replied (6/30): > > The importance in taking multiple cores from around the prostate is in > determining the percentage of cores which show up positive for prostate > cancer. Basically, if 50% or more come up positive, then there is > almost no chance that localized treatment will effect a cure. That may be over stating things a bit, but many people feel that the higher the % positive the cores are the less chance for a cure. In the end there is not a cut off number for which you have not chance of a cure, just factors that seem to decrease the chance of one.
> I replied to Ed F as follows (6/30): > > Thanks, Ed, this is the kind of answer I was looking for. The question > then becomes, what exactly is localized treatment? Surgery, yes. Seeds, > yes. All good options. I would also add Cryo which seems to have its place these days in some people view.
> Chemo through a catheter directly into the prostate, yes. Not so much.
> Intravenous chemotherapy, no. Sometimes, but not great from a cure point of view. More salvage therapy at this point.
> Whole body radiation, no. Radiation has its place, but not whole body.
> Another question is, just how finely localized can a treatment be? > Suppose just the firm nodule tests positive, but none of the surrounding > other 11 samples do. I wonder what the treatment would be. People have looked into this, but at this time not much good news from the point of view of the prostate "lumpectomy". Best to treat the whole gland in one way or the other if you are going to treat it.
> Ray ME
Richard - 06 Jul 2005 03:13 GMT I had a "firm spot" on my prostate that kept the doctors busy for about ten years. When my PSA went from 4.0 to 5.6 in 18 months, they did the third set of 6 biopsies, which showed cancer, but not in the area of the "nodule". I had RRP in November 1999 and have been cancer free for the past 5 years.
Richard
> On 6/30/05 3:42 PM, in article 1PYwe.4261$SQ1.2000@fe09.lga, "Ray K" > <raykosXXX@optonline.net> wrote: [quoted text clipped - 90 lines] > > ME Ed Friedman - 01 Jul 2005 17:44 GMT > I replied to Ed F as follows (6/30): > [quoted text clipped - 8 lines] > > Ray Ray,
Localized treatment encompasses all forms of surgery and radiation. The best alternative (in my opinion) can be seen by going to http://prostateweb.com
Read all that you can and educate yourself. Important facts to remember are (I can give references for any of these that you want):
1. Prostate cancer divides every 56 days, but is killed almost as fast as it grows. Normal doubling time exceeds 475 days. This means that you have time to educate yourself about your options.
2. The more aggressive the cancer (or the more core samples it is found in) the more likely some cells have already escaped the prostate and therefore a cure is impossible through localized treatment.
3. If you attempt localized treatment and fail, then the surviving cells will end up with a doubling time of less than 100 days (supposedly due to angiogenesis).
Good luck,
Ed Friedman
ron - 01 Jul 2005 19:25 GMT Ed Friedman wrote...snip...
> 1. Prostate cancer divides every 56 days, but is killed almost as fast > as it grows. Normal doubling time exceeds 475 days. This means that [quoted text clipped - 7 lines] > will end up with a doubling time of less than 100 days (supposedly due > to angiogenesis). Ed...I must be missing something. If, from #1, PCa divides / doubles every 56 days, then what information is being conveyed in #3 where you say "surviving cells will end up with a doubling time of less than 100 days"? Is less than 100 days different from 56 days? Also what do you mean by "supposedly due to angiogenisis", just what is due to angiogenesis...Thanks, Ron
Ed Friedman - 01 Jul 2005 19:32 GMT > Ed...I must be missing something. If, from #1, PCa divides / doubles > every 56 days, then what information is being conveyed in #3 where you > say "surviving cells will end up with a doubling time of less than 100 > days"? Is less than 100 days different from 56 days? Also what do you > mean by "supposedly due to angiogenisis", just what is due to > angiogenesis...Thanks, Ron Ron,
The doubling time is the average time for the population of cells to double. The division time is the average time for an individual cell to divide. So from #1, the cell divides in 56 days, but the population doubles in 475 days. In #3, the population will double in less than 100 days instead of 475 days.
The following quote, from http://www.prostatepointers.org/leibowitz/THB.11102.html may make things clearer:
An article in the Journal of Urology by Moul, Judd; Volume 165; pages 469-473; February 2001 reports “our results imply that tumor cell spillage at surgery may be responsible for recurrence (spread) of disease.” Yes, the conclusion is that surgery may be responsible for prostate cancer spreading. Dr. Thomas Stamey, noted urologist at Stanford (now retired), had pointed out that stage T1 or T2 prostate cancer untreated has a median PSA doubling time of four years, meaning it takes four years for a PSA to go from 1.5 to 3; or from 2 to 4, etc. However, the patients who fail radiation therapy or surgery have doubling times of usually less than 100 days. He commented that these patients might have been better off untreated. He additionally comments, “Thus, it is feasible that the surgeon who creates a positive margin at radical prostatectomy is similar to the radiation therapist....both convert a slowly progressive cancer into a rapidly advancing malignancy.”
Ed
Leonard Evens - 01 Jul 2005 20:20 GMT >> Ed...I must be missing something. If, from #1, PCa divides / doubles >> every 56 days, then what information is being conveyed in #3 where you [quoted text clipped - 31 lines] > > Ed How does this square with the results of the recent Swedish study in which pateints were randomly divided into two groups, half treated with RP and half with WW? If surgery were a significant factor in the spread of the disease, you would expect the WW group to do better with respect to evidence of spread and disease specific death rate. But they did signifcantly worse. Moreover their disadvantage vis-a-vis the RP group grew as more time passed.
Be that as it may, the trouble with quoting random papers is that the research literature on this subject is not consistent. If you look hard, you can find evidence supporting what you want to believe. That is particularly the case if you are not yourself an expert in the subject. One has to take all these things with more than a grain of salt.
Ed Friedman - 01 Jul 2005 20:58 GMT > How does this square with the results of the recent Swedish study in > which pateints were randomly divided into two groups, half treated with [quoted text clipped - 9 lines] > is particularly the case if you are not yourself an expert in the > subject. One has to take all these things with more than a grain of salt. To quote Dr. Leibowitz on the Swedish study:
"Of note is that men assigned to radical prostatectomy were treated on relapse with immediate hormone blockade, while those on watchful waiting had delayed therapy. Since many believe that early hormone blockade improves survival, this would bias the study against watchful waiting. I would point out that in the watchful waiting group, there were 21 Gleason 8-10's; only 14 in the radical prostatectomy group. There were more Gleason 7's in watchful waiting arm than the radical prostatectomy arm. Follow-up PSA results are not given. Obviously anyone with a rising PSA after radical prostatectomy would be considered a failure, but these results are not given. The authors also stressed that their results were obtained primarily in a group of men with clinically-detected prostate cancer, rather than the much more commonly PSA-detected prostate cancer that we now have. Only 10% of their patients were PSA-detected. In fact, one of their conclusions is that in men with cancer detected by PSA screening, the baseline risk of death from prostate cancer may be even lower since men survive years longer the earlier you diagnose their prostate cancer. If you only diagnose the disease when it has spread to the bones, survival is much shorter than PSA-detected cases. This means that for the first five to eight years after PSA-detected cases, most men will not die from prostate cancer, even without treatment. Any possible benefit from surgery would not be apparent for several more years. Thus, the absolute benefit of radical treatment, if any, may be even less pronounced for patients diagnosed by PSA screening (the way prostate cancer is usually diagnosed today in the USA) than the way men were diagnosed in this study."
From the above, I gather that RP patients were treated more aggressively (and sooner) to keep them alive, whereas WW patients were let go too long (bone mets) before starting treatment.
Also, if surgery removes 99.999% or so of the existing prostate cancer(PCa) cells, then even if the remaining cells are growing at a faster rate, it is still possible for WW patients to die sooner since they have so many more PCa cells to start with. The other point is that some men will be cured by the surgery, so that no one in their right mind would advocate WW over RP if they are interested in long term survival rates from PCa. The only reason to suggest WW over RP is if the patient is unlikely to live that much longer anyway (I think 10 years or less is the number usually given).
If you check over past postings to the alt.support.cancer.prostate newsgroup, you will see an occassional posting with a very sad description of men who had RP, then had their PSA skyrocket upwards shortly afterwards at a velocity much higher than they had prior to surgery. These would be those men unfortunate enough to have had substantial numbers of cells outside of their prostate at the time of their surgery. If you deny that surgery speeds the doubling time of surviving prostate cancer cells, then how do you explain those cases?
Ed Friedman
ron - 01 Jul 2005 23:14 GMT Ed Friedman wrote...snip...
> To quote Dr. Leibowitz on the Swedish study: > > "Of note is that men assigned to radical prostatectomy were treated on > relapse with immediate hormone blockade, while those on watchful waiting > had delayed therapy. Intervention in the two groups was the same when metastaic disease was diagnosed. For local recurrence in the WW arm (palpable tumor or obstructed urine flow requiring intervention), TURP was recommended. For symptomatic local progression in the RP arm (histologically confirmed local tumor) HT or orchiectomy was recommended.
> I would point out that in the watchful waiting group, there were 21 > Gleason 8-10's; only 14 in the radical prostatectomy group. There were > more Gleason 7's in watchful waiting arm than the radical prostatectomy > arm. These percentage differences are extremely small (1-2%)and far overshadowed by the roughly 10% of men in both groups who did not have a GS. PSA was better characterized (only1-2% of the men in each arm did not have a baseline PSA). For both PSA=10-20 and PSA>20 the surgery arm had 1-3% more of these men then the WW arm.
> From the above, I gather that RP patients were treated more > aggressively (and sooner) to keep them alive, whereas WW patients were > let go too long (bone mets) before starting treatment. Not sure I agree
> Also, if surgery removes 99.999% or so of the existing prostate > cancer(PCa) cells, then even if the remaining cells are growing at a [quoted text clipped - 5 lines] > the patient is unlikely to live that much longer anyway (I think 10 > years or less is the number usually given). Another reason to suggest WW is if a man is suspected of having indolent disease. It appears that 20-40% of newly diagnosed men fall into this category based on work by Moul, Klotz and Hopkins.
> If you check over past postings to the alt.support.cancer.prostate > newsgroup, you will see an occassional posting with a very sad [quoted text clipped - 4 lines] > their surgery. If you deny that surgery speeds the doubling time of > surviving prostate cancer cells, then how do you explain those cases? I've never seen such a sub-class mentioned in the literature. If you are noticing it in a newsgroup, wouldn't researchers have seen it in their data and published such findings?..Ron
ron - 01 Jul 2005 20:30 GMT Ed...I can't find that reference to Moul's work. None of Stamey's (or Folkman's) speculation on angiogenisis are supported by the Swedish papers that compared outcomes from RP and WW that have been discussed here...Ron
Alan Meyer - 01 Jul 2005 22:36 GMT > ... > The doubling time is the average time for the population of cells to double. The > division time is the average time for an individual cell to divide. So from #1, the > cell divides in 56 days, but the population doubles in 475 days. In #3, the population > will double in less than 100 days instead of 475 days. > ... I think I understand the arguments here. If cancerous prostate cells divide on average every 56 days, then the theoretical maximum doubling rate is 56 days. The actual doubling rate should always be less because some of the cells die. On average, the death rate is such that the doubling rate is 475 days with untreated cells.
It's the second part, that the doubling rate drops from 475 days down to 100 days after treatment, that requires explanation. It _especially_ requires explanation when it is claimed that that is true for both radiation and surgery patients.
> The following quote, from http://www.prostatepointers.org/leibowitz/THB.11102.html > may make things clearer: [quoted text clipped - 11 lines] > similar to the radiation therapist....both convert a slowly progressive cancer into a > rapidly advancing malignancy.” Dr. Stamey's comments surprise me.
The consensus in the past has been that "tumor cell spillage at surgery" does not spread cancer. Dr. Stamey argues that there is some evidence that it does. I'd like to see that argument made more carefully.
Some surgeons appear to have very high rates of cure. Is it the case that they have less spillage? Or is it simply that they are more effective at removing all of the prostate tissue whereas others don't get it all. One of the participants in alt.support.cancer.prostate reported that he discovered long after his RRP that half his prostate was still in his body.
Now the question is, why does the doubling rate get worse? Is the theory here that cells that have escaped the prostate (due to "surgical spillage") get access to more blood supply and therefore experience less cell death? If that's so, what in the world does radiation have to do with that? With radiation, there is no physical movement of cells. As far as I know, nothing that was organ confined is released to the blood stream by radiation.
Since the action of surgery and radiation are so radically different, it's hard to understand why they should have an identical effect on cancer cells.
Alan
Ed Friedman - 01 Jul 2005 23:08 GMT > Since the action of surgery and radiation are so radically different, it's > hard to understand why they should have an identical effect on > cancer cells. > > Alan Alan,
The explanation you are looking for is the angiogenesis theory, which to put simply states that the primary tumor mass releases chemicals which inhibit the growth of any metastases that exist. When the primary tumor mass is eliminated, the inhibition stops and metastases grow more rapidly.
Check out the paper "Excisional Therapy for cancer cure: therapy at a cost" in The Lancet Oncology, Vol. 4, Dec. 2003:760-768.
Another way to think of this is to ask yourself the question - who has longer to live, the man with a PSA of 8 with prostate cancer and no localized treatment or the man who has RP then has his PSA go up to 8?
Ed Friedman
Alan Meyer - 02 Jul 2005 00:16 GMT >> Since the action of surgery and radiation are so radically different, it's >> hard to understand why they should have an identical effect on [quoted text clipped - 17 lines] > > Ed Friedman Ed,
Thanks for the explanation.
I find your contrarian outlook on PCa refreshing. I don't know if you're right or wrong, but it's interesting to see someone looking at the same data that everybody else looks at and coming up with a different explanation.
Alan
Alan Meyer - 01 Jul 2005 21:28 GMT > ... > Some additional info not in the original post: PSA 9.8 (the previous high was 9.1 in > Sept 2002, with interim values of as low as 7.4 two months later following 2 weeks of > Cipro, and a reading of 8.8 in April 2004); nodule about 0.5 cm, based on DRE. > ... PSA can vary considerably from day to day based on prostate stress factors having nothing to do with cancer. It is important that you put no stress on the prostate for at least several days before a PSA test. No stress means no sex, no bike riding, no DRE, and nothing else that would stress the prostate.
Otherwise you get meaningless variations in the numbers.
> Ed replied (6/29): > > Once they have you there with the probe in place, let them take the > samples they need. ... I agree with Ed.
Something out of the ordinary is happening in your prostate. What would you do if you got one or few samples taken only from the nodule and they came back negative? Would you be reassured that you were cancer free? Or would you still be worried?
...
> Ed Friedman replied (6/30): > > The importance in taking multiple cores from around the prostate is in determining the > percentage of cores which show up positive for prostate cancer. Basically, if 50% or > more come up positive, then there is almost no chance that localized treatment will > effect a cure. I hadn't heard this one. I'd be curious to see the citations for it.
> ... > Another question is, just how finely localized can a treatment be? Suppose just the firm > nodule tests positive, but none of the surrounding other 11 samples do. I wonder what > the treatment would be. It is my understanding that partial prostatectomies are never attempted (though some are done inadvertently by clumsy or inexperienced surgeons who fail to remove the entire gland.)
As I understand it, the presence of cancer in any part of the prostate generally implies at least a microscopic presence of tumor cells in many places in the prostate. These scattered cells are difficult to find but are potentially capable of growing out of control - which is what cancer cells like to do.
Both radiation and surgery do considerable damage to the body, and not only to the prostate. Some of the damage heals and some is permanent. Some of it also makes later treatment more difficult. Whichever treatment you choose, you want to get it done just once, correctly, competently, and comprehensively. You don't want to have to go through the trauma multiple times.
I wouldn't be surprised if, some day, there will be treatments that go specifically to tumor cells and leave the rest of the prostate alone. Breast cancer treatment has evolved to the point where that can be done (lumpectomy vs. mastectomy). But it is my understanding that we're not there yet with prostate cancer. The prostate is harder to get to than the breast, smaller, and more connected to critical organs. So the current "best practice" is to treat the entire prostate with surgery or radiation.
Alan
Ed Friedman - 01 Jul 2005 22:36 GMT >>Ed Friedman replied (6/30): >> [quoted text clipped - 4 lines] > > I hadn't heard this one. I'd be curious to see the citations for it. I heard this at a recent lecture on prostate cancer that I attended. However, a quick google search showed the following from: http://www.prostate-cancer.org/education/riskases/scholz_newlydiagnosed.html
"For patients who have more than 50% of core biopsies positive, we automatically raised one sub stage from that initially assigned by the Kattan nomogram. For example, when the nomogram indicates a Risk Category IB, we would raise the Risk Category to IC. Risk Category IC patients would be raised to Risk Category II."
The lecturer I heard stated that for otherwise low risk patients, virtually all of the deaths came from those with more than 50% of the cores positive.
Ed Friedman
|
|
|